ArticleFrontiers in pharmacology2024

A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system.

Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.